farnesol and Carcinoma, Pancreatic Ductal

farnesol has been researched along with Carcinoma, Pancreatic Ductal in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Azizian, NG; Du, R; Li, Y; Liu, Y; Sullivan, DK	1

Other Studies

1 other study(ies) available for farnesol and Carcinoma, Pancreatic Ductal

Article	Year
Inhibition of ERAD synergizes with FTS to eradicate pancreatic cancer cells. BMC cancer, 2021, Mar-06, Volume: 21, Issue:1 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; CRISPR-Cas Systems; Drug Screening Assays, Antitumor; Endoplasmic Reticulum-Associated Degradation; Farnesol; Gene Knockout Techniques; Humans; Hydrazones; Hydroxyurea; Mice; Pancreatic Neoplasms; Proteins; Salicylates; Synthetic Lethal Mutations; Ubiquitin-Protein Ligases; Unfolded Protein Response	2021

Article

Year

Inhibition of ERAD synergizes with FTS to eradicate pancreatic cancer cells.

BMC cancer, 2021, Mar-06, Volume: 21, Issue:1

Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; CRISPR-Cas Systems; Drug Screening Assays, Antitumor; Endoplasmic Reticulum-Associated Degradation; Farnesol; Gene Knockout Techniques; Humans; Hydrazones; Hydroxyurea; Mice; Pancreatic Neoplasms; Proteins; Salicylates; Synthetic Lethal Mutations; Ubiquitin-Protein Ligases; Unfolded Protein Response

2021